The World Vaccine Congress Europe will be back in October 2026 bringing together industry experts across the entire vaccine landscape from the likes of WHO, Gavi, UNICEF, Africa CDC, GSK, Moderna, IVI and the European Commission, CEPI and more. With six parallel tracks, the congress covers the whole vaccine value chain, from basic research to commercial manufacture. The congress will host 2,000+ attendees, 280 speakers, 150+ exhibitors and start-ups over the course of 3 days.
The World Vaccine Congress is an award-winning series of conferences and exhibitions that has grown to become the largest and most established vaccine meeting of its kind across the globe since 2000.
The World Vaccine Congress is an award-winning series of conferences and exhibitions that has grown to become the largest and most established vaccine meeting of its kind across the globe since 2000. It offers a unique opportunity to explore cutting-edge developments, forge partnerships, and drive progress in vaccine innovation.
The Congress will host 2,000+ attendees, 280 speakers, 150+ exhibitors and start-ups, bringing together global leaders, scientists, and industry experts across the entire vaccine landscape.
| Time | Session | Speaker(s) |
|---|---|---|
| 14:00 | Reducing Zero-Dose Vaccinations in Africa: Digital Strategies and Continental Initiatives | Fidele Ngabo Gaga, Head of RMNCAH, Africa CDC |
| 14:15 | Global market landscape of vaccine manufacturing and procurement for improved access | Georgios Stathopoulos, WHO |
| 15:45 | Gavi, the Vaccine Alliance: Driving Global Vaccine Access and Market Shaping | Maria Verykiou, Gavi |
| 16:30 | Novel combination vaccines against endemic pathogens for children under 5 | Farzana Muhib, PATH |
| 16:45 | Novel approaches to measure the value of combination vaccines | Frédéric Debellut, Senior Health Economist, PATH |
| Time | Session | Speaker(s) |
|---|---|---|
| 10:15 | Keynote: One Shot, Many Frontiers — Combination Vaccines for a Healthier Lifetime | Mark Jit (NYU), Birgitte Giersing (WHO), Melanie Saville (PATH), Maria Elena Bottazzi (Baylor), Nicola Rose (MHRA), Rituparna Das (Moderna) |
| 14:00 | Pragmatic Randomised Vaccine Trials: Generating the Evidence Policymakers Need | University of Copenhagen |
| 16:00 | Panel: Expanding the Access & Impact of Adjuvants (IP and licensing barriers) | CEPI, Baylor, Vaccine Formulation Institute |
| 16:15 | Eliminating the Cold Chain: a fridge-free Td vaccine | Stablepharma |
| Time | Session | Speaker(s) |
|---|---|---|
| 09:00 | Keynote: The New Geopolitics of Vaccines — Global Vaccine Manufacturing in a Fractured World | Afrigen, Africa CDC (Manufacturing), UNICEF, European Commission, Hilleman Labs; moderated by Access to Medicine Foundation |
| 10:45 | Panel: Emerging Outbreaks at the Front Line | Africa CDC, Gates Foundation, Oxford, GSK, CSL Seqirus; moderated by UKHSA |
| 11:20 | Cost-effective manufacturing at commercial scale: reducing footprint, labour and COGS | Univercells Technologies |
| 12:00 | Working group: how do we ensure priority combination vaccines are developed, licensed and used? | Kate O’Brien (WHO), Birgitte Giersing (WHO), Farzana Muhib (PATH), Sciensano |
| 13:00 | Global Manufacturing and Access Strategy for a TB Vaccine: MTBVAC | Biofabri |
| 13:30 | Panel: Rethinking AMR Priorities — Choosing the Targets That Move the Needle | WHO, IAVI, PATH South Asia, WOAH, Amsterdam UMC; moderated by European Vaccine Initiative |